124 related articles for article (PubMed ID: 36442771)
21. Roles of the PI3K/Akt pathway and autophagy in TLR3 signaling-induced apoptosis and growth arrest of human prostate cancer cells.
Harashima N; Inao T; Imamura R; Okano S; Suda T; Harada M
Cancer Immunol Immunother; 2012 May; 61(5):667-76. PubMed ID: 22038398
[TBL] [Abstract][Full Text] [Related]
22. NPRL2 promotes docetaxel chemoresistance in castration resistant prostate cancer cells by regulating autophagy through the mTOR pathway.
Luo S; Shao L; Chen Z; Hu D; Jiang L; Tang W
Exp Cell Res; 2020 May; 390(2):111981. PubMed ID: 32234375
[TBL] [Abstract][Full Text] [Related]
23. Benzyl isothiocyanate induces protective autophagy in human prostate cancer cells via inhibition of mTOR signaling.
Lin JF; Tsai TF; Liao PC; Lin YH; Lin YC; Chen HE; Chou KY; Hwang TI
Carcinogenesis; 2013 Feb; 34(2):406-14. PubMed ID: 23172666
[TBL] [Abstract][Full Text] [Related]
24. Sequential combination of flavopiridol and docetaxel reduces the levels of X-linked inhibitor of apoptosis and AKT proteins and stimulates apoptosis in human LNCaP prostate cancer cells.
Gomez LA; de Las Pozas A; Perez-Stable C
Mol Cancer Ther; 2006 May; 5(5):1216-26. PubMed ID: 16731754
[TBL] [Abstract][Full Text] [Related]
25. FOXM1 contributes to docetaxel resistance in castration-resistant prostate cancer by inducing AMPK/mTOR-mediated autophagy.
Lin JZ; Wang WW; Hu TT; Zhu GY; Li LN; Zhang CY; Xu Z; Yu HB; Wu HF; Zhu JG
Cancer Lett; 2020 Jan; 469():481-489. PubMed ID: 31738958
[TBL] [Abstract][Full Text] [Related]
26. Inhibiting PAD2 enhances the anti-tumor effect of docetaxel in tamoxifen-resistant breast cancer cells.
Li F; Miao L; Xue T; Qin H; Mondal S; Thompson PR; Coonrod SA; Liu X; Zhang X
J Exp Clin Cancer Res; 2019 Oct; 38(1):414. PubMed ID: 31601253
[TBL] [Abstract][Full Text] [Related]
27. Piperlongumine induces apoptosis and autophagy in human lung cancer cells through inhibition of PI3K/Akt/mTOR pathway.
Wang F; Mao Y; You Q; Hua D; Cai D
Int J Immunopathol Pharmacol; 2015 Sep; 28(3):362-73. PubMed ID: 26246196
[TBL] [Abstract][Full Text] [Related]
28. Autophagy Induction by α-Santalol in Human Prostate Cancer Cells.
Walters C; Reed M; Bartholomew S; Bommareddy A
Anticancer Res; 2021 Mar; 41(3):1197-1202. PubMed ID: 33788710
[TBL] [Abstract][Full Text] [Related]
29. siRNA-mediated silencing of Notch-1 enhances docetaxel induced mitotic arrest and apoptosis in prostate cancer cells.
Ye QF; Zhang YC; Peng XQ; Long Z; Ming YZ; He LY
Asian Pac J Cancer Prev; 2012; 13(6):2485-9. PubMed ID: 22938409
[TBL] [Abstract][Full Text] [Related]
30. Dual role of autophagy on docetaxel-sensitivity in prostate cancer cells.
Cristofani R; Montagnani Marelli M; Cicardi ME; Fontana F; Marzagalli M; Limonta P; Poletti A; Moretti RM
Cell Death Dis; 2018 Aug; 9(9):889. PubMed ID: 30166521
[TBL] [Abstract][Full Text] [Related]
31. Ginsenoside Rg5 induces apoptosis and autophagy via the inhibition of the PI3K/Akt pathway against breast cancer in a mouse model.
Liu Y; Fan D
Food Funct; 2018 Nov; 9(11):5513-5527. PubMed ID: 30207362
[TBL] [Abstract][Full Text] [Related]
32. The Impact of Icariside II on Human Prostate Cancer Cell Proliferation, Mobility, and Autophagy via PI3K-AKT-mTOR Signaling Pathway.
Li S; Zhan Y; Xie Y; Wang Y; Liu Y
Drug Des Devel Ther; 2020; 14():4169-4178. PubMed ID: 33116405
[TBL] [Abstract][Full Text] [Related]
33. Targeting Btk/Etk of prostate cancer cells by a novel dual inhibitor.
Guo W; Liu R; Bhardwaj G; Yang JC; Changou C; Ma AH; Mazloom A; Chintapalli S; Xiao K; Xiao W; Kumaresan P; Sanchez E; Yeh CT; Evans CP; Patterson R; Lam KS; Kung HJ
Cell Death Dis; 2014 Sep; 5(9):e1409. PubMed ID: 25188519
[TBL] [Abstract][Full Text] [Related]
34. Tau oligomers accumulation sensitizes prostate cancer cells to docetaxel treatment.
Martellucci S; Clementi L; Sabetta S; Muzi P; Mattei V; Bologna M; Angelucci A
J Cancer Res Clin Oncol; 2021 Jul; 147(7):1957-1971. PubMed ID: 33811272
[TBL] [Abstract][Full Text] [Related]
35. Dual Akt and Bcl-2 inhibition induces cell-type specific modulation of apoptotic and autophagic signaling in castration resistant prostate cancer cell lines.
Avsar Abdik E; Abdik H; Turan D; Sahin F; Berger MR; Kaleagasioglu F
Mol Biol Rep; 2021 Dec; 48(12):7755-7765. PubMed ID: 34647221
[TBL] [Abstract][Full Text] [Related]
36. Citrate activates autophagic death of prostate cancer cells via downregulation CaMKII/AKT/mTOR pathway.
Fan X; Zhou J; Yan X; Bi X; Liang J; Lu S; Luo L; Zhou D; Yin Z
Life Sci; 2021 Jun; 275():119355. PubMed ID: 33744326
[TBL] [Abstract][Full Text] [Related]
37. Luteoloside induces G
Zhou M; Shen S; Zhao X; Gong X
Biochem Biophys Res Commun; 2017 Dec; 494(1-2):263-269. PubMed ID: 29024631
[TBL] [Abstract][Full Text] [Related]
38. Neuregulin promotes incomplete autophagy of prostate cancer cells that is independent of mTOR pathway inhibition.
Schmukler E; Shai B; Ehrlich M; Pinkas-Kramarski R
PLoS One; 2012; 7(5):e36828. PubMed ID: 22606295
[TBL] [Abstract][Full Text] [Related]
39. Piperlongumine promotes autophagy via inhibition of Akt/mTOR signalling and mediates cancer cell death.
Makhov P; Golovine K; Teper E; Kutikov A; Mehrazin R; Corcoran A; Tulin A; Uzzo RG; Kolenko VM
Br J Cancer; 2014 Feb; 110(4):899-907. PubMed ID: 24434432
[TBL] [Abstract][Full Text] [Related]
40. Identification of ML-9 as a lysosomotropic agent targeting autophagy and cell death.
Kondratskyi A; Yassine M; Slomianny C; Kondratska K; Gordienko D; Dewailly E; Lehen'kyi V; Skryma R; Prevarskaya N
Cell Death Dis; 2014 Apr; 5(4):e1193. PubMed ID: 24763050
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]